Translating Digital Health from the Clinic to Market Access and Commercial Success
From the 2024 PODD Conference, panelists from Genentech, EMD Serono, Otsuka Precision Health and SHL Medical discuss approaches to enable connected devices and digital health to improve patients engagement and adherence as well as improve chances of new therapeutics’ approval and commercialization.
Summary:
This webcast features a panel discussion on approaches to enable connected devices and digital health to improve patients engagement and adherence as well as improve chances of new therapeutics’ approval and commercialization, with representatives from Genentech, EMD Serono, Otsuka Precision Health and SHL Medical from the 2024 PODD Conference.
The panelists discuss how digital technologies and enable faster and more precise clinical trials, improve patient experience, enable better data collection and lead to success both in clinical trials and after commercialization.
To learn more about the PODD Conference and affiliated drug delivery content, please visit, drug-delivery.org.